Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lineage Cell Therapeutics (LCTX) Tax Rate: 2019-2023

Historic Tax Rate for Lineage Cell Therapeutics (LCTX) over the last 3 years, with Dec 2023 value amounting to 7.74%.

  • Lineage Cell Therapeutics' Tax Rate was N/A to 29.05% in Q1 2023 from the same period last year, while for Mar 2023 it was 65.32%, marking a year-over-year change of. This contributed to the annual value of 7.74% for FY2023, which is N/A change from last year.
  • Lineage Cell Therapeutics' Tax Rate amounted to 7.74% in FY2023, which was up 37.03% from 5.65% recorded in FY2020.
  • Lineage Cell Therapeutics' Tax Rate's 5-year high stood at 38.51% during FY2019, with a 5-year trough of 5.65% in FY2020.
  • Moreover, its 1-year median value for Tax Rate was 7.74% (2023), whereas its average is 7.74%.
  • Data for Lineage Cell Therapeutics' Tax Rate shows a maximum YoY slumped of 3,286bps (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Lineage Cell Therapeutics' Tax Rate stood at 38.51% in 2019, then plummeted by 3,286bps to 5.65% in 2020, then reached 7.74% in 2023.